Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. J&J Innovative Medicine

J&J Innovative Medicine

What you need to know about Johnson & Johnson’s 2022 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

How Johnson & Johnson is supporting mental healthcare in the Hispanic and Latino communities

From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Mental Health Awareness Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.

“I’m working to develop better treatments for children with devastating diseases”

A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.

Meet 3 men who’ve been on the front lines of HIV treatments for decades

Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.

What you need to know about Johnson & Johnson’s 2022 second-quarter earnings

Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

5 things we now know about the tropical disease dengue

As global temperatures continue to rise, so too does the incidence of this mosquito-borne virus. For World Neglected Tropical Disease Day, learn the latest about this growing health threat and how Johnson & Johnson is working to combat it.

5 things we now know about Crohn’s disease

Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn’s disease—and what other potential breakthroughs are on the horizon.

What you need to know about Johnson & Johnson’s 2022 first-quarter earnings

Check out this infographic breakdown of the company’s first-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

“We want a world without tuberculosis in our lifetimes”

Healthcare providers who contracted TB on the job. A microbiologist researching new treatments. An activist ensuring attention is paid to one of the world’s greatest health threats. These young leaders share one goal: to help end TB.

What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.